In tumor cells, normal signaling is frequently impaired due to increased expression of or mutations in receptor-tyrosine kinases (RTKs), such as the epidermal growth factor receptor (EGFR) (reviewed in Ref.2). This evidence concerns the gene EGFR and neoplasm.